Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
3755studies shown
Showing 169-180 of 3,755
Drug study icon
RecruitingNCT05511363

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in the United Kingdom, ...

Multiple locations, including Orange
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06126224

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Canada, in the United Kingdom, ...

Multiple locations, including Stuart
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06540833

ITI-1284 for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Croatia, ...

Multiple locations, including Anaheim
SchizophreniaDrugOver 55 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
Drug study icon
RecruitingNCT06887192

ML-007C-MA for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Canada, ...

Multiple locations, including Phoenix
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, Canada, ...
Sponsor
MapLight Therapeutics
Condition
Schizophrenia
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

Multiple locations, including Bentonville
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06585787

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Belgium, ...

Multiple locations, including Gilbert
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, Belgium, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06947941

Safety and Efficacy of KarXT + KarX-EC for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

Multiple locations, including Gilbert
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, Australia, Canada, ...
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
RecruitingNCT07221877

Effect of KarXT on Urological Safety

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.